On the public citation graph

Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine

0 signed · 131 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/bimj.200610229openalex-snapshot
A Regulatory View on Adaptive/Flexible Clinical Trial Design
inferredcites →https://doi.org/10.1002/bimj.200610249openalex-snapshot
A Consultant's Perspective on the Regulatory Hurdles to Adaptive Trials
inferredcites →https://doi.org/10.1002/hec.1454openalex-snapshot
Spending on new drug development1
inferredcites →https://doi.org/10.1002/pst.221openalex-snapshot
Operational challenges in adaptive design implementation
inferredcites →https://doi.org/10.1002/sim.3538openalex-snapshot
Adaptive designs for confirmatory clinical trials
inferredcites →https://doi.org/10.1002/sim.4102openalex-snapshot
Adaptive increase in sample size when interim results are promising: A practical guide with examples
inferredcites →https://doi.org/10.1002/sim.4148openalex-snapshot
Targeting population entering phase III trials: A new stratified adaptive phase II design
inferredcites →https://doi.org/10.1002/sim.4211openalex-snapshot
How a new stratified adaptive phase II design could improve targeting population
inferredcites →https://doi.org/10.1002/sim.735openalex-snapshot
The continual reassessment method and its applications: a Bayesian methodology for phase I cancer clinical trials
inferredcites →https://doi.org/10.1007/s10928-005-0074-7openalex-snapshot
How Modeling and Simulation Have Enhanced Decision Making in New Drug Development
inferredcites →https://doi.org/10.1007/s10928-010-9171-3openalex-snapshot
Quantitative clinical pharmacology is transforming drug regulation
inferredcites →https://doi.org/10.1016/b978-0-12-373639-0.00025-xopenalex-snapshot
Modern Drug Discovery and Development
inferredcites →https://doi.org/10.1016/j.ahj.2010.06.042openalex-snapshot
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
inferredcites →https://doi.org/10.1016/j.anai.2010.04.006openalex-snapshot
Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) Study
inferredcites →https://doi.org/10.1016/j.bcp.2005.08.019openalex-snapshot
Systems and integrative biology as alternative guises for pharmacology: Prime time for an iPharm concept?
inferredcites →https://doi.org/10.1016/j.cell.2008.09.008openalex-snapshot
The Discovery of Statins
inferredcites →https://doi.org/10.1016/j.ddtec.2007.11.001openalex-snapshot
FDA's Critical Path Initiative
inferredcites →https://doi.org/10.1016/j.pupt.2010.01.003openalex-snapshot
Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design
inferredcites →https://doi.org/10.1016/s0009-9236(97)90160-0openalex-snapshot
Learning versus confirming in clinical drug development*
inferredcites →https://doi.org/10.1016/s0140-6736(00)04560-8openalex-snapshot
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
inferredcites →https://doi.org/10.1016/s0140-6736(00)05059-5openalex-snapshot
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
inferredcites →https://doi.org/10.1016/s0140-6736(10)61350-5openalex-snapshot
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
inferredcites →https://doi.org/10.1016/s0167-6296(02)00126-1openalex-snapshot
The price of innovation: new estimates of drug development costs
inferredcites →https://doi.org/10.1016/s1471-4914(01)01986-4openalex-snapshot
Clinical application of pharmacogenetics
inferredcites →https://doi.org/10.1021/mp700094sopenalex-snapshot
Mathematical Modeling of Corticosteroid Pharmacogenomics in Rat Muscle following Acute and Chronic Methylprednisolone Dosing
inferredcites →https://doi.org/10.1038/477526aopenalex-snapshot
Translational research: 4 ways to fix the clinical trial
inferredcites →https://doi.org/10.1038/clpt.1989.108openalex-snapshot
Study designs for dose-ranging
inferredcites →https://doi.org/10.1038/clpt.2009.68openalex-snapshot
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
inferredcites →https://doi.org/10.1038/clpt.2010.279openalex-snapshot
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
inferredcites →https://doi.org/10.1038/msb.2011.71openalex-snapshot
Systematic exploration of synergistic drug pairs
inferredcites →https://doi.org/10.1038/msb4100116openalex-snapshot
Chemical combination effects predict connectivity in biological systems
inferredcites →https://doi.org/10.1038/msb4100133openalex-snapshot
Networks from drug–drug surfaces
inferredcites →https://doi.org/10.1038/nchembio817openalex-snapshot
Systems biology and combination therapy in the quest for clinical efficacy
inferredcites →https://doi.org/10.1038/ni.1688openalex-snapshot
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
inferredcites →https://doi.org/10.1038/nrd1202openalex-snapshot
Target discovery
inferredcites →https://doi.org/10.1038/nrd1347openalex-snapshot
Cutting the cost of drug development?
inferredcites →https://doi.org/10.1038/nrd1927openalex-snapshot
Bayesian clinical trials
inferredcites →https://doi.org/10.1038/nrd2124openalex-snapshot
Adapting to circumstances
inferredcites →https://doi.org/10.1038/nrd3025openalex-snapshot
The future of drug development: advancing clinical trial design
inferredcites →https://doi.org/10.1038/nrg1321openalex-snapshot
RNA regulation: a new genetics?
inferredcites →https://doi.org/10.1038/nrg2918openalex-snapshot
Network medicine: a network-based approach to human disease
inferredcites →https://doi.org/10.1038/sj.clpt.6100045openalex-snapshot
Paving the Critical Path: How can Clinical Pharmacology Help Achieve the Vision?
inferredcites →https://doi.org/10.1038/sj.clpt.6100085openalex-snapshot
Medical Product Development and Regulatory Science for the 21st Century: The Critical Path Vision and Its Impact on Health Care
inferredcites →https://doi.org/10.1038/sj.tpj.6500387openalex-snapshot
Overview of the pharmacogenetics of asthma treatment
inferredcites →https://doi.org/10.1053/euhj.2000.2243openalex-snapshot
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14
inferredcites →https://doi.org/10.1056/nejm199808133390704openalex-snapshot
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
inferredcites →https://doi.org/10.1056/nejmoa010746openalex-snapshot
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
inferredcites →https://doi.org/10.1056/nejmoa042739openalex-snapshot
Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease
inferredcites →https://doi.org/10.1056/nejmoa1103782openalex-snapshot
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
inferredcites →https://doi.org/10.1056/nejmp1109621openalex-snapshot
The Risks and Benefits of Indacaterol — The FDA's Review
inferredcites →https://doi.org/10.1056/nejmsb030228openalex-snapshot
The Therapeutic Orientation to Clinical Trials
inferredcites →https://doi.org/10.1073/pnas.1119675109openalex-snapshot
The mystery of missing heritability: Genetic interactions create phantom heritability
inferredcites →https://doi.org/10.1080/10543400600614742openalex-snapshot
Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group
inferredcites →https://doi.org/10.1080/10543406.2010.514455openalex-snapshot
Review of Draft FDA Adaptive Design Guidance
inferredcites →https://doi.org/10.1080/10543406.2011.552878openalex-snapshot
Regulatory Perspectives on Multiplicity in Adaptive Design Clinical Trials throughout a Drug Development Program
inferredcites →https://doi.org/10.1093/acprof:osobl/9780199896202.003.0014openalex-snapshot
The therapeutic orientation to clinical trials
inferredcites →https://doi.org/10.1093/jnci/89.15.1138openalex-snapshot
Accelerated Titration Designs for Phase I Clinical Trials in Oncology
inferredcites →https://doi.org/10.1124/jpet.106.104117openalex-snapshot
An Overview of Drug Combination Analysis with Isobolograms
inferredcites →https://doi.org/10.1126/science.273.5281.1516openalex-snapshot
The Future of Genetic Studies of Complex Human Diseases
inferredcites →https://doi.org/10.1126/science.274.5287.536openalex-snapshot
The New Genomics: Global Views of Biology
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1961openalex-snapshot
Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
inferredcites →https://doi.org/10.1160/th11-08-0566openalex-snapshot
Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
inferredcites →https://doi.org/10.1161/01.cir.99.21.2720openalex-snapshot
Abciximab Facilitates the Rate and Extent of Thrombolysis
inferredcites →https://doi.org/10.1161/10.1161/01.atv.0000194548.11901.a4openalex-snapshot
Mechanisms of Statin-Induced Myopathy
inferredcites →https://doi.org/10.1161/circulationaha.108.809707openalex-snapshot
Optimizing Trial Design
inferredcites →https://doi.org/10.1161/circulationaha.111.089243openalex-snapshot
Personalized Cardiovascular Medicine and Drug Development
inferredcites →https://doi.org/10.1164/rccm.200902-0166ocopenalex-snapshot
The Prevalence of Nonadherence in Difficult Asthma
inferredcites →https://doi.org/10.1177/0091270011406280openalex-snapshot
Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON‐TIMI 38 Substudy
inferredcites →https://doi.org/10.1177/1087057106292473openalex-snapshot
High-Throughput Screening: Update on Practices and Success
inferredcites →https://doi.org/10.1177/1087057111405379openalex-snapshot
Open Innovation for Phenotypic Drug Discovery: The PD2 Assay Panel
inferredcites →https://doi.org/10.1177/1740774510375455openalex-snapshot
Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials
inferredcites →https://doi.org/10.1177/216847900604000408openalex-snapshot
Adaptive Designs: Terminology and Classification
inferredcites →https://doi.org/10.1186/1745-6215-12-134openalex-snapshot
Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication
inferredcites →https://doi.org/10.1186/1750-1172-3-11openalex-snapshot
Adaptive design methods in clinical trials – a review
inferredcites →https://doi.org/10.1186/1750-1172-6-79openalex-snapshot
Benefits, challenges and obstacles of adaptive clinical trial designs
inferredcites →https://doi.org/10.1258/0007142001903535openalex-snapshot
Heterogeneity of therapeutic responses in asthma
inferredcites →https://doi.org/10.1371/journal.pone.0000097openalex-snapshot
A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle
inferredcites →https://doi.org/10.2139/ssrn.869765openalex-snapshot
Spending on New Drug Development
inferredcites →https://doi.org/10.2174/138161209789649466openalex-snapshot
Genetic Mapping of Pharmacogenetic Regulatory Variation
inferredcites →https://doi.org/10.2217/14622416.9.8.1133openalex-snapshot
Molecular Basis for Statin-Induced Muscle Toxicity: Implications and Possibilities
inferredcites →https://doi.org/10.4103/0253-7613.68417openalex-snapshot
Adaptive design clinical trials: Methodology, challenges and prospect
inferredcites →https://doi.org/10.7326/0003-4819-130-6-199903160-00005openalex-snapshot
Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1001/jama.2012.14841openalex-snapshot
Transforming Clinical Trials in Cardiovascular Disease
inferred← citeshttps://doi.org/10.1002/wsbm.1198openalex-snapshot
Promise of personalized omics to precision medicine
inferred← citeshttps://doi.org/10.1002/wsbm.1253openalex-snapshot
Systems biology‐embedded target validation: improving efficacy in drug discovery
inferred← citeshttps://doi.org/10.1002/wsbm.1294openalex-snapshot
Systems engineering meets quantitative systems pharmacology: from low‐level targets to engaging the host defenses
inferred← citeshttps://doi.org/10.1002/wsbm.1297openalex-snapshot
Systems medicine: evolution of systems biology from bench to bedside
inferred← citeshttps://doi.org/10.1007/978-3-319-53868-6_2openalex-snapshot
Networks and Pathways in Systems Pharmacology
inferred← citeshttps://doi.org/10.1007/s00018-012-1109-zopenalex-snapshot
Systems biology for molecular life sciences and its impact in biomedicine
inferred← citeshttps://doi.org/10.1007/s00439-016-1636-zopenalex-snapshot
Improved prediction of complex diseases by common genetic markers: state of the art and further perspectives
inferred← citeshttps://doi.org/10.1007/s40495-014-0014-6openalex-snapshot
Architecture of Signature miRNA Regulatory Networks in Cancer Chemoprevention
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12334-0openalex-snapshot
Systems Chemical Biology: Integrating Medicinal Chemistry and Systems Biology for Drug Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-443-29808-0.00025-xopenalex-snapshot
Systems chemical biology: Integrating medicinal chemistry and systems biology for drug discovery
inferred← citeshttps://doi.org/10.1016/b978-0-444-63964-6.00001-5openalex-snapshot
Quantitative systems pharmacology: Extending the envelope through systems engineering
inferred← citeshttps://doi.org/10.1016/j.dmpk.2024.101020openalex-snapshot
Practical QSP application from the preclinical phase to enhance the probability of clinical success: Insights from case studies in oncology
inferred← citeshttps://doi.org/10.1016/j.molmed.2015.02.009openalex-snapshot
Genetics and the placebo effect: the placebome
inferred← citeshttps://doi.org/10.1016/j.tips.2013.09.004openalex-snapshot
Pharmacological tools for the development of traditional Chinese medicine
inferred← citeshttps://doi.org/10.1038/nrcardio.2016.101openalex-snapshot
Precision medicine in cardiology
inferred← citeshttps://doi.org/10.1038/s41571-019-0273-6openalex-snapshot
A systems approach to clinical oncology uses deep phenotyping to deliver personalized care
inferred← citeshttps://doi.org/10.1042/cs20160407openalex-snapshot
Personalized medicine—a modern approach for the diagnosis and management of hypertension
inferred← citeshttps://doi.org/10.1080/15321819.2018.1562940openalex-snapshot
Multiplex assay for multiomics advances in personalized-precision medicine
inferred← citeshttps://doi.org/10.1089/omi.2013.0055openalex-snapshot
Tamoxifen Integromics and Personalized Medicine: Dynamic Modular Transformations Underpinning Response to Tamoxifen in Breast Cancer Treatment
inferred← citeshttps://doi.org/10.1093/femsyr/fox027openalex-snapshot
The genetic architecture in Saccharomyces cerevisiae that contributes to variation in drug response to the antifungals benomyl and ketoconazole
inferred← citeshttps://doi.org/10.1097/aci.0b013e32836093ddopenalex-snapshot
From phenotypes to endotypes to asthma treatment
inferred← citeshttps://doi.org/10.1109/bibe.2013.6701554openalex-snapshot
Exploitation of patient avatars towards stratified medicine through the development of in silico clinical trials approaches
inferred← citeshttps://doi.org/10.1111/febs.12268openalex-snapshot
Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-010814-124543openalex-snapshot
Pharmacogenomics in Asthma Therapy: Where Are We and Where Do We Go?
inferred← citeshttps://doi.org/10.1161/cir.0000000000000211openalex-snapshot
Future Translational Applications From the Contemporary Genomics Era
inferred← citeshttps://doi.org/10.1161/cir.0000000000000224openalex-snapshot
Saving and Improving Lives in the Information Age
inferred← citeshttps://doi.org/10.1161/circresaha.111.258541openalex-snapshot
The Emerging Paradigm of Network Medicine in the Study of Human Disease
inferred← citeshttps://doi.org/10.1161/circulationaha.116.023555openalex-snapshot
The Future of Cardiovascular Therapeutics
inferred← citeshttps://doi.org/10.1161/jaha.115.002810openalex-snapshot
Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape
inferred← citeshttps://doi.org/10.1172/jci129203openalex-snapshot
The application of big data to cardiovascular disease: paths to precision medicine
inferred← citeshttps://doi.org/10.1177/1535370217750088openalex-snapshot
Biomarker definitions and their applications
inferred← citeshttps://doi.org/10.1186/gm436openalex-snapshot
Are randomized trials obsolete or more important than ever in the genomic era?
inferred← citeshttps://doi.org/10.1253/circj.cj-14-0459openalex-snapshot
Clinical Research and the Development of Medical Therapeutics
inferred← citeshttps://doi.org/10.20416/lsrsps.v4i2.983openalex-snapshot
Médecine de précision et médecine des systèmes: La médecine personnalisée se trompet-elle de cible ?
inferred← citeshttps://doi.org/10.21203/rs.3.rs-8206489/v1openalex-snapshot
Mapping the biomarker landscape of Biofield Therapies: An exploration of measurable effects
inferred← citeshttps://doi.org/10.2174/156802662019200701164759openalex-snapshot
Experimental and Computational Approaches to Improve Binding Affinity in Chemical Biology and Drug Discovery
inferred← citeshttps://doi.org/10.2174/9789815165616123010007openalex-snapshot
Application of Multi-scale Modeling Techniques in System Biology
inferred← citeshttps://doi.org/10.25557/0031-2991.2018.03.95-105openalex-snapshot
Current directions in development of postgenomic medical technologies
inferred← citeshttps://doi.org/10.26686/wgtn.17014628openalex-snapshot
Investigating the Quantitative Trait Loci Contributing to Individual Variation in Drug Response
inferred← citeshttps://doi.org/10.2741/s400openalex-snapshot
Adaptive network nanomedicine an integrated model for homeopathic medicine
inferred← citeshttps://doi.org/10.3389/fcvm.2026.1842597openalex-snapshot
Pharmacogenomics-guided therapy for essential hypertension: a multi-center randomized controlled open-label trial
inferred← citeshttps://doi.org/10.3389/fphar.2017.00155openalex-snapshot
Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine
inferred← citeshttps://doi.org/10.3390/biology13100762openalex-snapshot
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification
inferred← citeshttps://doi.org/10.3390/cancers13246312openalex-snapshot
Can Systems Biology Advance Clinical Precision Oncology?
inferred← citeshttps://doi.org/10.3390/jpm10040180openalex-snapshot
Systems Biology and Experimental Model Systems of Cancer
inferred← citeshttps://doi.org/10.3892/ol.2020.11672openalex-snapshot
Identification of key genes for guiding chemotherapeutic management in ovarian cancer using translational bioinformatics
inferred← citeshttps://doi.org/10.4018/979-8-3373-6400-1.ch014openalex-snapshot
Integrating Multi-Omics Data Using AI
inferred← citeshttps://doi.org/10.7324/japs.2019.90407openalex-snapshot
A novel approach in glioblastoma multiforme drug discovery: perturbation studies in vitro
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.